1. Home
  2. RPAY vs SGHT Comparison

RPAY vs SGHT Comparison

Compare RPAY & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repay Holdings Corporation

RPAY

Repay Holdings Corporation

HOLD

Current Price

$3.78

Market Cap

314.6M

ML Signal

HOLD

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$8.36

Market Cap

309.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RPAY
SGHT
Founded
2006
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
314.6M
309.6M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
RPAY
SGHT
Price
$3.78
$8.36
Analyst Decision
Buy
Buy
Analyst Count
8
7
Target Price
$5.53
$9.08
AVG Volume (30 Days)
431.1K
221.6K
Earning Date
05-04-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.16
EPS
N/A
N/A
Revenue
$309,261,000.00
$77,363,000.00
Revenue This Year
$12.54
$11.67
Revenue Next Year
$4.66
$10.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.30
$3.19
52 Week High
$5.90
$9.24

Technical Indicators

Market Signals
Indicator
RPAY
SGHT
Relative Strength Index (RSI) 44.50 85.70
Support Level $3.39 $8.00
Resistance Level $3.87 $8.93
Average True Range (ATR) 0.19 0.51
MACD -0.04 0.32
Stochastic Oscillator 20.66 94.58

Price Performance

Historical Comparison
RPAY
SGHT

About RPAY Repay Holdings Corporation

Repay Holdings Corp is a payments technology company. It provides integrated payment processing solutions to industry-oriented vertical markets in which businesses or other organizations have specific transaction processing needs. It allows customers to pay through Mobile App, Text, Interactive Voice Response, Virtual Terminal, Hosted Payment Page and Online Customer Portal among others. It operates in two segments Consumer Payments and Business Payments. The company generates majority of its revenue from Consumer Payments segment.

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

Share on Social Networks: